Peter Weiden, MD
Board Certified xyz |
xyz xyz |
xyz xyz |
abc xyz |
Dr. Weiden’s career has focused on improving clinical outcomes for patients with schizophrenia. His research has focused on bridging psychopharmacology and public health issues in the treatment of schizophrenia, and he has a particular interest in pharmacologic and psychosocial interventions to help patients and clinicians address medication adherence barriers.
Dr. Weiden earned his BA in Chemistry from Swarthmore College and his MD from the State University of New York at Stony Brook. He completed his psychiatric residency at the Payne Whitney Clinic–New York Hospital and a psychiatric epidemiology fellowship at the Mailman School of Public Health of Columbia University.